- •Data Collection of Primary
- •Portions of this presentation are based on
- •Part I
- •Rationale for Non-malignant CNS
- •History 1992 -1996
- •History 1998
- •BTWG Recommendations (1)
- •BTWG Recommendations (2)
- •BTWG Recommendations (3)
- •History 2000
- •History 2001-2002
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •Reportable Brain-Related Tumors
- •History 2003
- •Impact of Collecting Data on Non-malignant CNS Tumors (1)
- •Impact of Collecting Data on Non-malignant CNS Tumors (2)
- •Impact of Collecting Data on Non-malignant CNS Tumors (3)
- •Impact of Collecting Data on Non-malignant CNS Tumors (4)
- •Case-finding (1)
- •Case-finding (2)
- •Case-finding Sources
- •ICD-9-CM Codes for Case- finding
- •Unusual and Ambiguous
- •Part II
- •CNS Functional Anatomy
- •CNS Anatomy
- •Intracranial Sites
- •Cerebrum
- •Cerebellum and Brain Stem
- •The Ventricular System
- •Pineal and Pituitary Glands
- •Cranial Nerves
- •Meninges
- •Tentorium
- •Spinal Cord
- •Cellular Classification
- •Glial Tumors (1)
- •Glial Tumors (2)
- •Glial Tumors (3)
- •Glial Tumors (4)
- •Non-Glial Tumors (1)
- •Non-Glial Tumors (2)
- •Other CNS Tumors (1)
- •Other CNS Tumors (2)
- •Other CNS Tumors (3)
- •Other CNS Tumors (4)
- •Childhood versus Adult
- •Childhood Brain Tumors
- •Cellular Classification
- •Cellular Classification
- •Cellular Classification
- •ICD-O-3 Coding Issues (1)
- •ICD-O-3 Coding Issues (2)
- •Grade for CNS Tumors
- •WHO Grade (1)
- •WHO Grade (2)
- •Kernohan Grade
- •St. Anne-Mayo Grade (1)
- •St. Anne-Mayo Grade (2)
- •Grade for CNS Tumors
- •Part III
- •Determining Multiple
- •Coding Laterality (1)
- •Coding Laterality (2)
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •Determining Multiple
- •General Rules for Determining Multiple Primaries of CNS Sites
- •General Rules for Determining
- •General Rules for Determining
- •Histologic Transformation (1)
- •Histologic Transformation (2)
- •Histologic Transformation (3)
- •Histologic Transformation (4)
- •Histologic Transformation (5)
- •Coding Sequence Numbers
- •Coding Sequence Numbers
- •Coding Sequence Numbers
- •Assigning Diagnosis Date
- •Part IV
- •Collaborative Stage (CS)
- •Coding Collaborative Stage
- •Coding Collaborative Stage
- •CS Extension: Brain and
- •CS Extension: Brain and
- •CS Extension: Brain and
- •CS Extension: Brain and
- •CS Extension: Other CNS
- •CS Extension: Other CNS
- •CS Extension: Other CNS
- •CS Extension: Other Endocrine
- •CS Lymph Nodes
- •CS Metastasis at Diagnosis
- •CS Metastasis at Diagnosis
- •CS Site-specific Factor 1 (1)
- •CS Site-specific Factor 1 (2)
- •Possible Risk Factors
- •Possible Risk Factors
- •Genetic Syndromes
- •Diagnostic Tools – Physical Exam
- •Diagnostic Tools: Radiology
- •Diagnostic Tools: Laboratory
- •Diagnostic Tools
- •College of American Pathologist
- •Brain and Spinal Cord
- •Brain and Spinal Cord
- •Treatment (1)
- •Treatment (2)
- •Surgical Procedure of Primary
- •Site
- •Surgical Procedure of Primary
- •Surgical Procedure of Primary
- •Surgical Procedure of Primary
- •Surgical Procedure of Primary
- •Surgical Procedure of Primary
- •Surgical Margins of the Primary
- •Scope of Regional Lymph Node
- •Radiation Therapy (1)
- •Radiation Therapy (2)
- •Radiation Therapy (3)
- •Radiation Therapy (3)
- •Radiation Therapy (4)
- •Radiation Therapy (5)
- •Chemotherapy (1)
- •Chemotherapy (2)
- •Chemotherapy (3)
- •Hormone Therapy
- •Immunotherapy (1)
- •Immunotherapy (2)
- •Hematologic Transplant and
- •Technical Issues
- •Technical Issues
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •Acknowledgments (1)
- •Acknowledgments (2)
- •Acknowledgments (3)
- •Acknowledgments (4)
References
Websites (continued)
•College of American Pathologists (CAP), Protocol – Brain ftp://ftp.cap.org/cancerprotocols/Brain0 3_p.doc
•Illustrated Glossary of Radiology: Anatomy, Examinations and Procedures; Department of Radiology and Radiological Services, The Uniformed Services University of the Health Sciences http://rad.usuhs.mil/glossary.html 151
References
Websites (continued)
•International RadioSurgery Association www.isra.org/index.html
•National Brain Tumor Radiosurgery Association www.braintumors.com/radiosurgery/r adiosrugery.info#TWO
•NCI Brain Tumor Home Page www.nci.nih.gov/cancer_information/c ancer_type/brain_tumor
/
152
References
Websites (continued)
•PDQ Cancer Information Summaries: Adult Treatment www.cancer.gov/cancerinfo/pdq/adultt reatment
•PDQ Cancer Information Summaries: Pediatric Treatment www.cancer.gov/cancerinfo/pdq/pediatr ictreatment
•The Brain Tumor Foundation www.braintumorfoundation.org/neurosu rgery/ss3_3.htm
153
Acknowledgments (1)
Prepared by Shannon Vann, CTR for the
North American Association of Central Cancer Registries (NAACCR)
This training presentation was supported by contract #200- 2001-00044 from CDC. The content of this training presentation does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
154
Acknowledgments (2)
Sponsors
•Centers for Disease Control and Prevention
–National Program for Cancer Registries
•National Cancer Institute
–Surveillance, Epidemiology and End Results Program
•North American Association of Central Cancer Registries
•American Joint Committee on Cancer
•Collaborative Stage Task Force
155
Acknowledgments (3)
CDC National Program of Cancer
Registries Planning Committee
Kimberly Cantrell
Gayle G. Clutter
Faye Floyd
Michael Lanzilotta
Frances Michaud
156
Acknowledgments (4)
Materials Review Committee
Trista Aarnes-LeongSt. Vincent Medical Center, NAACCR Registry Operations Subcommittee, |
|||
Susan Bolick-AldrichSouth Carolina Central Cancer Registry, NAACCR Registry Operations |
|||
Subcommittee, Chair, Co-chair, Registry Operations Committee |
|
||
Gayle Clutter |
CDC National Program of Cancer Registries, Registry Operations |
|
|
Subcommittee, National Coordination Council on Cancer Surveillance Brain Tumor |
|
||
Working |
Group, Chair |
|
|
Faye Floyd |
CDC National Program of Cancer Registries |
|
|
April Fritz |
NCI Surveillance, Epidemiology and End Results Program, Registry |
|
|
Operations |
Subcommittee |
|
|
Elaine Hamlyn |
Canadian Cancer Registry, Registry Operations Subcommittee, |
|
|
Holly Howe |
North American Association of Central Cancer Registries, Executive |
|
|
Director |
New Jersey State Cancer Registry, NAACCR Education Committee |
|
|
Betsy Kohler |
|
||
Carol Kruchko |
Central Brain Tumor Registry of the United States, Registry Operations |
||
Subcommittee, National Coordination Council on Cancer Surveillance Brain Tumor |
|||
Working Group |
Cancer Surveillance Program of Los Angeles. Registry Operations |
|
|
Donna Morrel |
|
||
Subcommittee |
North Carolina Central Cancer Registry, Registry Operations |
|
|
Linda Mulvihill |
|
||
Subcommittee |
Minnesota Cancer Surveillance Program |
|
|
Wendy Scharber |
|
||
James Smirniotopoulos |
Professor of Radiology, Uniformed Services University, Registry |
||
Operations Subcommittee |
|
|
|
Katheryne Vance |
California Cancer Registry, Registry Operations Subcommittee |
|
|
Valerie Vesich |
American College of Surgeons, Commission on Cancer, Registry |
|
|
Operations |
Subcommittee |
157 |
|
|
|
|